TD Asset Management’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Sell |
124,164
-16,637
| -12% | -$2.77M | 0.02% | 518 |
|
|
2026
Q1 | $29.5M | Buy |
140,801
+96,682
| +219% | +$24.3M | 0.02% | 430 |
|
|
2025
Q4 | $12.5M | Buy |
44,119
+4,551
| +12% | +$1.42M | 0.01% | 603 |
|
|
2025
Q3 | $12.2M | Buy |
39,568
+10,815
| +38% | +$3.39M | 0.01% | 606 |
|
|
2025
Q2 | $9.03M | Buy |
28,753
+3,765
| +15% | +$1.09M | 0.01% | 658 |
|
|
2025
Q1 | $6.56M | Sell |
24,988
-304
| -1% | -$82.3K | 0.01% | 736 |
|
|
2024
Q4 | $6.6M | Buy |
25,292
+1,106
| +5% | +$279K | 0.01% | 742 |
|
|
2024
Q3 | $5.61M | Sell |
24,186
-26,316
| -52% | -$5.4M | 0.01% | 774 |
|
|
2024
Q2 | $10.2M | Sell |
50,502
-2,057
| -4% | -$371K | 0.01% | 615 |
|
|
2024
Q1 | $9.01M | Sell |
52,559
-16,410
| -24% | -$3.06M | 0.01% | 648 |
|
|
2023
Q4 | $15M | Sell |
68,969
-13,959
| -17% | -$2.39M | 0.01% | 535 |
|
|
2023
Q3 | $13.2M | Buy |
82,928
+24,959
| +43% | +$5.59M | 0.02% | 525 |
|
|
2023
Q2 | $16.7M | Sell |
57,969
-2,617
| -4% | -$795K | 0.02% | 479 |
|
|
2023
Q1 | $19.3M | Buy |
60,586
+12,404
| +26% | +$3.68M | 0.02% | 450 |
|
|
2022
Q4 | $14.2M | Buy |
48,182
+4,556
| +10% | +$1.26M | 0.02% | 515 |
|
|
2022
Q3 | $10.1M | Sell |
43,626
-170
| -0.4% | -$42.6K | 0.01% | 581 |
|
|
2022
Q2 | $9.54M | Sell |
43,796
-1,195
| -3% | -$272K | 0.01% | 621 |
|
|
2022
Q1 | $12M | Buy |
44,991
+7,040
| +19% | +$1.73M | 0.01% | 612 |
|
|
2021
Q4 | $10.1M | Buy |
37,951
+654
| +2% | +$190K | 0.01% | 681 |
|
|
2021
Q3 | $10.6M | Sell |
37,297
-293
| -0.8% | -$83.6K | 0.01% | 641 |
|
|
2021
Q2 | $10.5M | Buy |
37,590
+1,565
| +4% | +$425K | 0.01% | 635 |
|
|
2021
Q1 | $9.4M | Buy |
36,025
+1,772
| +5% | +$475K | 0.01% | 658 |
|
|
2020
Q4 | $8.76M | Buy |
34,253
+2,093
| +7% | +$519K | 0.01% | 636 |
|
|
2020
Q3 | $7.61M | Buy |
32,160
+6,551
| +26% | +$1.38M | 0.01% | 607 |
|
|
2020
Q2 | $4.97M | Buy |
25,609
+3,809
| +17% | +$728K | 0.01% | 665 |
|
|
2020
Q1 | $3.61M | Sell |
21,800
-100
| -0.5% | -$18.3K | 0.01% | 695 |
|
|
2019
Q4 | $3.75M | Sell |
21,900
-4,700
| -18% | -$783K | 0.01% | 781 |
|
|
2019
Q3 | $4.39M | Buy |
26,600
+3,300
| +14% | +$464K | 0.01% | 713 |
|
|
2019
Q2 | $2.78M | Buy |
23,300
+3,200
| +16% | +$328K | ﹤0.01% | 839 |
|
|
2019
Q1 | $1.91M | Buy |
20,100
+6,700
| +50% | +$574K | ﹤0.01% | 914 |
|
|
2018
Q4 | $1.06M | Sell |
13,400
-2,600
| -16% | -$220K | ﹤0.01% | 1043 |
|
|
2018
Q3 | $1.7M | Hold |
16,000
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q2 | $1.37M | Buy |
16,000
+7,000
| +78% | +$628K | ﹤0.01% | 1053 |
|
|
2018
Q1 | $780K | Buy |
+9,000
| New | +$699K | ﹤0.01% | 1119 |
|
|
2014
Q2 | – | Sell |
-22,700
| Closed | -$1.08M | – | 1308 |
|
|
2014
Q1 | $1.08M | Sell |
22,700
-2,600
| -10% | -$115K | ﹤0.01% | 898 |
|
|
2013
Q4 | $939K | Buy |
25,300
+6,400
| +34% | +$236K | ﹤0.01% | 893 |
|
|
2013
Q3 | $685K | Sell |
18,900
-7,500
| -28% | -$252K | ﹤0.01% | 922 |
|
|
2013
Q2 | $829K | Buy |
+26,400
| New | +$748K | ﹤0.01% | 860 |
|
Other funds holding PODD
VCM
VPM
SCM
TD Asset Management's PODD Position: Q2 2026 in Review
TD Asset Management reduced its Insulet (PODD) stake by 12% in Q2 2026, selling an estimated $2.77M and leaving 124,164 shares worth $18.9M. The position accounts for 0.02% of the portfolio, ranked #518.
TD Asset Management first reported a position in PODD in Q2 2013 and has held it in 38 quarters since. The position peaked at $29.5M in Q1 2026. 561 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- TD Asset Management held 124,164 shares of Insulet worth $18.9M as of Q2 2026.
- TD Asset Management sold 16,637 Insulet shares in Q2 2026, an estimated $2.77M.
- Insulet made up 0.02% of TD Asset Management's portfolio in Q2 2026, its #518 holding.
- TD Asset Management first reported a position in Insulet in Q2 2013 and has held it in 38 quarters since.
- TD Asset Management's Insulet position peaked at $29.5M in Q1 2026.
- 561 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.